Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 130.60
+3.28 (2.58%)
May 27, 2026, 4:10 PM AEST
Pro Medicus Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $182.17. The average 1-year stock price forecast is 39.49% higher than the current stock price, while the lowest is $54.00 (-58.65%) and the highest is $245.00 (+87.60%).
Price Target: $182.17 (+39.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 7 | 7 | 9 |
| Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Hold | 6 | 5 | 4 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 13 | 13 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $207.90 | Buy | Maintains | $207.90 | +59.19% | May 19, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $190.00 → $195.00 | Hold | Maintains | $190.00 → $195.00 | +49.31% | May 18, 2026 |
Unknown Analyst Ord Minnett No rating | Ord Minnett | Buy Maintains $220.00 → $210.00 | Buy | Maintains | $220.00 → $210.00 | +60.80% | May 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $180.82 → $168.62 | Buy | Maintains | $180.82 → $168.62 | +29.11% | May 12, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $200.00 | Buy | Maintains | $200.00 | +53.14% | Apr 30, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.